The novel three-dose rabies vaccine received the top honour at the India Pharma World Awards.
Ahmedabad: Cadila Pharmaceuticals’ breakthrough three-dose rabies vaccine, ThRabis, has won the top honour at the prestigious India Pharma World Awards, warding off competition from formidable players in the pharma industry.
ThRabis was named as the winner in the category “Pharma Innovation of the Year Award” in front of the who’s who of the Indian pharmaceutical industry.
“ ThRabis is a breakthrough vaccine and is developed through state-of-the-art technology. It has the potential to save thousands of lives in India and globally.
ThRabis will be a game changer in the prevention of Rabies and is the most effective intervention to eliminate Rabies by 2030.
This award is a huge recognition of years of untiring efforts of our scientists and reflection of Cadila Pharmaceuticals’ commitment to innovation to ensure the availability of affordable medicines and vaccines to patients in India and globally,” said Dr. Rajiv I. Modi, Chairman, and Managing Director, Cadila Pharmaceuticals Limited.
Cadila Pharmaceuticals launched the ThRabis vaccine, a novel three-dose recombinant nanoparticle-based rabies G protein vaccine, in April last year.
Other existing rabies vaccines require five injections spread over 28 days to complete the full regimen. Many animal bite victims are unable to complete the full course of the vaccine due to a complicated dosing schedule, frequent visits to the hospital or clinic, and potential loss of income because of the visits.
This leaves many victims unprotected and susceptible to developing rabies. ThRabis, on the other hand, is a three-dose regimen vaccine, and a game-changer in the fight to eliminate rabies through a simpler and more convenient regimen.
The India Pharma World Awards are an initiative of The Economic Times aimed at recognizing and acknowledging efforts of ground-breaking innovation.
The awards celebrate the advancements and innovations of the pharma industry. The winners were selected by eminent juries.
About Cadila Pharmaceuticals Ltd
Cadila Pharmaceuticals Ltd. (www.cadilapharma.com) is one of the largest privately-held pharmaceutical companies in India.
Over the past seven decades, Cadila Pharmaceuticals has been engaged in the development and manufacturing of affordable medicines and in making them available for patients across the world.
Its innovation-driven drug discovery processes ensure the health and well-being of people around the world.
|Are you an
Entrepreneur or Startup?
Do you have a Success Story to Share?
SugerMint would like to share your success story.
We cover entrepreneur Stories, Startup News, Women entrepreneur stories, and Startup stories
Read more Press Releases at SugerMint.